Search
for

    GlossaryTofacitinib (Xeljanz)

    inhibits Janus kinase enzymes to treat autoimmune conditions

    Tofacitinib, also known by the brand name Xeljanz, is a medication that inhibits Janus kinase (JAK) enzymes, which play a role in the inflammatory process. It is used to treat autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis, and has also shown promise in treating alopecia areata, a condition that causes hair loss.

    Related Terms

    Learn

    1 / 1 results

      learn Tofacitinib

      a JAK inhibitor for alopecia areata and other autoimmune conditions

    Research

    5 / 113 results

    Community Join

    5 / 8 results

      community Xeljanz....the magic drug!!!

       2 upvotes 6 years ago
      A user experienced significant hair regrowth from Xeljanz after severe alopecia but can no longer afford it. They are seeking ways to obtain the medication despite its high cost and potential side effects.

      community Anyone with LPP have regrowth with Xeljanz?

      in Treatment  3 upvotes 4 months ago
      The conversation is about using Xeljanz for hair regrowth in individuals with LPP. The user is seeking experiences and expectations from others who have tried this treatment.

      community Has anyone hear of the drug called Xeljanz?

      in Question  3 upvotes 8 years ago
      The conversation discusses hair loss treatments, specifically mentioning Minoxidil, finasteride, RU58841, and Xeljanz. The user inquires about Xeljanz and shares a link suggesting it may help with hair loss.

      community Alopecia Areata Question

      in Treatment  2 upvotes 3 years ago
      A user with alopecia totalis, borderline universalis, seeks advice on getting into a Xeljanz trial or appealing insurance for coverage. They experienced significant hair regrowth but are now seeing hair loss again and want to try Xeljanz.